CDE ID | CDE Description | * 421 | EDRN Participant ID (Go To: 423) |
* 423 | EDRN Protocol ID (Go To: 422) |
* 422 | EDRN Site ID (Go To: 929) |
* 929 | EDRN Staff ID of the person who collected the data: (Go To: 774) |
* 774 | Date of surgery (MM/DD/YYYY): (Go To: 1589) |
* 1589 | Primary Gleason grade: (Go To: 1590) |
* 1590 | Secondary Gleason grade: (Go To: 1696) |
1696 | Tertiary Gleason Pattern: (Go To: 1697) |
* 1697 | Overall Gleason Score: (Go To: 3405) |
* 3405 | Percentage of tumor tissue with Gleason Pattern 4: (Go To: 2610) |
* 2610 | Prostate T-Stage, Pathologic: (Go To: 2611) |
| Permissible Values (value): | pT2 (13) |
|
| |
| |
| |
| |
| |
| |
| |
| |
* 2611 | Prostate N-Stage, Pathologic: (Go To: 2612) |
| Permissible Values (value): | pNX (1) |
|
| |
| |
* 2612 | Prostate M-Stage, Pathologic: (Go To: 1687) |
| Permissible Values (value): | MX (1) |
|
| |
| |
| |
| |
| |
* 1687 | Total number of lymph nodes examined : (Go To: 2613) |
* 2613 | Number of lymph nodes with cancer: (Go To: 2722) |
* 2722 | Prostate volume (cc): (Go To: 2614) |
* 2614 | Estimated tumor volume (cc): (Go To: 3404) |
* 3404 | Percent of cancer in organ: (Go To: 1591) |
* 1591 | Perineural invasion: (Go To: 2618) |
| Permissible Values (value): | Present (1) |
|
| |
| |
* 2618 | Margin status (presence of cancer at margin): (Go To: 2626) |
| Permissible Values (value): | Positive (1) (Go To: 2619) |
|
| |
| | Uncertain (borderline case) (3) |
|
| |
* 2619 | Site(s) of positive margin(s): (Go To: 2626) |
| Permissible Values (value): | Anterior right (1) |
|
| |
| |
| |
| |
* 2626 | Extraprostatic extension (EPE) status: (Go To: 2628) |
| Permissible Values (value): | Positive (1) (Go To: 2627) |
|
| |
| | Uncertain (borderline case) (3) (Go To: 2627) |
|
| |
* 2627 | Extraprostatic extension (EPE) site(s): (Go To: 2628) |
| Permissible Values (value): | Anterior right (1) |
|
| |
| |
| |
* 2628 | Seminal vesicle invasion? (Go To: 2716) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 2629 | Seminal vesicle invasion site: (Go To: 2716) |
| Permissible Values (value): | Right (1) |
|
| |
| |
| |
| |
* 2716 | Are specimens available for review? (Go To: 4627) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 4627 | Was a MRI performed? (Go To: 4541) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 955 | Date of imaging test (MM/DD/YYYY): (Go To: 4628) |
* 4628 | Was a lesion suspicious for cancer discovered? (Go To: 4541) |
| Permissible Values (value): | No (0) |
|
| |
| |
* 4541 | Was a MRI/US Fusion Biopsy performed? (Go To: 1097) |
| Permissible Values (value): | No (0) |
|
| |
| |
1097 | Comments (do not include any participant identifiers) (Go To: End of Form) |